Sign In

CPG Infobase: Clinical Practice Guidelines

0 comment(s)

Record Id:
13759
Title:
Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada : pharmacologic management of type 2 diabetes
Fulltext:
View HTML (primary care)
Author
Harper W, Clement M, Goldenberg R, Hanna A, Main A, Retnakaran R, et al
Publication/Review date:
2013-Apr 
Producers:
Diabetes Canada
Fund Source:
Merck Frosst Canada
Novartis Pharmaceuticals Canada
Novo-Nordisk Canada
Astra Zeneca Canada
Eli Lilly Canada
Bristol-Myers Squibb

Bibliographic Source

Journal Citation:
Can J Diabetes 2013;37(suppl 1):S61-S68.
Pages/Size:
8  Page(s)
References:
111

Subject Information

Specialties:
Endocrinology and metabolism, Family practice,
Conditions:
Diabetes;
Domains:
Treatment, Diagnosis
Target Populations:
General
Target Gender:
Unknown
MeSH:
Hemoglobin A, Glycosylated; Hypoglycemic Agents; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Diabetes Mellitus; Hypoglycemia; Metformin;

Copyright:

The copyright of this guideline and its companion documents belongs to: Diabetes Canada

Disclaimer:
All content is provided for information and education and not as a substitute for the advice of a physician. Joule assumes no responsibility or liability arising from any error or omission or from the use of any information contained herein.

Discuss this CPG

Share your ideas and expertise on this topic.

​​​